Literature DB >> 24106872

Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users.

J H P van Wel1, K P C Kuypers, E L Theunissen, S W Toennes, D B Spronk, R J Verkes, J G Ramaekers.   

Abstract

BACKGROUND AND
PURPOSE: Cannabis is the most popular drug used in the European Union, closely followed by cocaine. Whereas cannabis impairs neurocognitive function in occasional cannabis users, such impairments appear less prominent in heavy users, possibly as a result of tolerance. The present study was designed to assess whether the impairing effects of Δ(9) -tetrahydrocannabinol (THC) in heavy cannabis users would present in a wide range of neuropsychological functions or selectively affect specific performance domains. We also assessed the acute effects of cocaine on neurocognitive functions of heavy cannabis users. EXPERIMENTAL APPROACH: Heavy cannabis users, who had a history of cocaine use (n = 61), participated in a double-blind, placebo-controlled, three-way crossover study. Subjects received single doses of cocaine HCl (300 mg), cannabis (THC μg·kg(-1) ) and placebo, and completed a number of tests measuring impulse control and psychomotor function. KEY
RESULTS: Single doses of cannabis impaired psychomotor function and increased response errors during impulsivity tasks. Single doses of cocaine improved psychomotor function and decreased response time in impulsivity tasks, but increased errors. CONCLUSIONS AND IMPLICATIONS: Heavy cannabis users display impairments in a broad range of neuropsychological domains during THC intoxication. Impairments observed in psychomotor tasks, but not in impulsivity tasks, appeared smaller in magnitude as compared with those previously reported in occasional cannabis users. Heavy cannabis users were sensitive to the stimulating and inhibitory effects of cocaine on psychomotor function and impulsivity respectively. The reduction in proficiency in impulse control may put drug users at increased risk of repeated drug use and addiction.
© 2013 The British Pharmacological Society.

Entities:  

Keywords:  addiction; cannabis; cocaine; cross-tolerance; impulsivity; tolerance

Mesh:

Substances:

Year:  2013        PMID: 24106872      PMCID: PMC3838687          DOI: 10.1111/bph.12425

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

1.  Cocaine improves inhibitory control in a human model of response conflict.

Authors:  Mark T Fillmore; Craig R Rush; Lon Hays
Journal:  Exp Clin Psychopharmacol       Date:  2005-11       Impact factor: 3.157

2.  Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study.

Authors:  Nina B L Urban; Mark Slifstein; Judy L Thompson; Xiaoyan Xu; Ragy R Girgis; Sonia Raheja; Margaret Haney; Anissa Abi-Dargham
Journal:  Biol Psychiatry       Date:  2012-01-29       Impact factor: 13.382

3.  Influence of ethanol on cannabinoid pharmacokinetic parameters in chronic users.

Authors:  Stefan W Toennes; Kirsten Schneider; Gerold F Kauert; Cora Wunder; Manfred R Moeller; Eef L Theunissen; Johannes G Ramaekers
Journal:  Anal Bioanal Chem       Date:  2010-11-30       Impact factor: 4.142

4.  Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study.

Authors:  Emma Barkus; Paul D Morrison; D Vuletic; John C Dickson; Peter J Ell; Lyn S Pilowsky; Rudolf Brenneisen; David W Holt; John Powell; Shitij Kapur; Robin M Murray
Journal:  J Psychopharmacol       Date:  2010-09-17       Impact factor: 4.153

5.  Neurophysiological and cognitive effects of smoked marijuana in frequent users.

Authors:  Carl L Hart; Aaron B Ilan; Alan Gevins; Erik W Gunderson; Kemi Role; Jana Colley; Richard W Foltin
Journal:  Pharmacol Biochem Behav       Date:  2010-06-18       Impact factor: 3.533

Review 6.  Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance.

Authors:  Raul Gonzalez
Journal:  Neuropsychol Rev       Date:  2007-09       Impact factor: 7.444

7.  Comparison of cannabinoid pharmacokinetic properties in occasional and heavy users smoking a marijuana or placebo joint.

Authors:  Stefan W Toennes; Johannes G Ramaekers; Eef L Theunissen; Manfred R Moeller; Gerold F Kauert
Journal:  J Anal Toxicol       Date:  2008-09       Impact factor: 3.367

8.  Balanced placebo design with marijuana: pharmacological and expectancy effects on impulsivity and risk taking.

Authors:  Jane Metrik; Christopher W Kahler; Brady Reynolds; John E McGeary; Peter M Monti; Margaret Haney; Harriet de Wit; Damaris J Rohsenow
Journal:  Psychopharmacology (Berl)       Date:  2012-05-16       Impact factor: 4.530

9.  Effects of endocannabinoid system modulation on cognitive and emotional behavior.

Authors:  Claudio Zanettini; Leigh V Panlilio; Mano Alicki; Steven R Goldberg; József Haller; Sevil Yasar
Journal:  Front Behav Neurosci       Date:  2011-09-13       Impact factor: 3.558

10.  Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study.

Authors:  Rebecca Kuepper; Jenny Ceccarini; Johan Lataster; Jim van Os; Marinus van Kroonenburgh; Joop M A van Gerven; Machteld Marcelis; Koen Van Laere; Cécile Henquet
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

View more
  9 in total

1.  Smoked cannabis' psychomotor and neurocognitive effects in occasional and frequent smokers.

Authors:  Nathalie A Desrosiers; Johannes G Ramaekers; Emeline Chauchard; David A Gorelick; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2015-03-04       Impact factor: 3.367

2.  Acute and chronic effects of cannabidiol on Δ⁹-tetrahydrocannabinol (Δ⁹-THC)-induced disruption in stop signal task performance.

Authors:  David S Jacobs; Stephen J Kohut; Shan Jiang; Spyros P Nikas; Alexandros Makriyannis; Jack Bergman
Journal:  Exp Clin Psychopharmacol       Date:  2016-08-15       Impact factor: 3.157

3.  The effects of heroin administration and drug cues on impulsivity.

Authors:  Jermaine D Jones; Nehal P Vadhan; Rachel R Luba; Sandra D Comer
Journal:  J Clin Exp Neuropsychol       Date:  2016-04-10       Impact factor: 2.475

4.  Effects of High-Potency Cannabis on Psychomotor Performance in Frequent Cannabis Users.

Authors:  Hollis C Karoly; Michael A Milburn; Ashley Brooks-Russell; Mary Brown; Jessica Streufert; Angela D Bryan; Nicholas P Lovrich; William DeJong; L Cinnamon Bidwell
Journal:  Cannabis Cannabinoid Res       Date:  2020-09-10

5.  Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes.

Authors:  J G Ramaekers; J H van Wel; D Spronk; B Franke; G Kenis; S W Toennes; K P C Kuypers; E L Theunissen; P Stiers; R J Verkes
Journal:  Brain Imaging Behav       Date:  2016-12       Impact factor: 3.978

Review 6.  Endocannabinoids and striatal function: implications for addiction-related behaviours.

Authors:  Fabricio A Moreira; Bianca Jupp; David Belin; Jeffrey W Dalley
Journal:  Behav Pharmacol       Date:  2015-02       Impact factor: 2.293

7.  A single dose of cocaine enhances prospective memory performance.

Authors:  Nadia Rpw Hutten; Kim Pc Kuypers; Janelle Hp van Wel; Eef L Theunissen; Stefan W Toennes; Robbert-Jan Verkes; Johannes G Ramaekers
Journal:  J Psychopharmacol       Date:  2018-06-27       Impact factor: 4.153

8.  Acute effects of cocaine and cannabis on reversal learning as a function of COMT and DRD2 genotype.

Authors:  Desirée B Spronk; Marieke E Van der Schaaf; Roshan Cools; Ellen R A De Bruijn; Barbara Franke; Janelle H P van Wel; Johannes G Ramaekers; Robbert J Verkes
Journal:  Psychopharmacology (Berl)       Date:  2015-11-17       Impact factor: 4.530

9.  Cannabis and tolerance: acute drug impairment as a function of cannabis use history.

Authors:  J G Ramaekers; J H van Wel; D B Spronk; S W Toennes; K P C Kuypers; E L Theunissen; R J Verkes
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.